Fundz

Azitra, Inc. Secures Funding Through Private Placement

PUBLIC · AZTRNov 25, 2025

Amount Raised

$5 Million

Round Type

Post-IPO Equity

BranfordBiotechnologyTherapeutics

Description

On November 24, 2025, Azitra, Inc. entered into a securities purchase agreement with a single institutional investor. The agreement involves a private placement offering at a premium to market, in accordance with NYSE rules. This funding will support the company's ongoing development efforts.

Quick answer

Azitra raised $5 Million in a Post-IPO Equity round, dated November 25, 2025. Azitra is based in Branford, Connecticut, United States.

How much did Azitra raise?
Azitra raised $5 Million in a Post-IPO Equity round on November 25, 2025.
What does Azitra do?
Azitra is a clinical-stage biopharmaceutical company developing precision dermatology therapies using engineered strains of S. epidermidis.
Where is Azitra based and how big is it?
Azitra is based in Branford, Connecticut, United States. Fundz records about 12 employees.
Who are the decision-makers at Azitra?
Fundz holds 2 contacts at Azitra, including the Chief Financial Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Azitra that raised within 45 days of this round, from Fundz verified event records.

  • AirNexis Therapeutics raised $62M on January 9, 2026.
  • Aurora Therapeutics raised $16M (Seed) on January 9, 2026.
  • Caldera Therapeutics raised $38M on January 8, 2026.
  • Beacon Therapeutics raised $75M (Series C) on January 8, 2026.
  • Parabilis Medicines raised $305M (Series F) on January 8, 2026.
  • STRM.BIO raised $8M (Seed) on January 7, 2026.

Who to call at Azitra, and when

A new round usually means Azitra is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Azitra raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Azitra, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Azitra. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Azitra

Location

21 BUSINESS PARK DRIVE, SUITE 6

Branford, Connecticut, United States

About

Azitra is a clinical-stage biopharmaceutical company developing precision dermatology therapies using engineered strains of S. epidermidis. Its lead program, ATR-12, is in a Phase 1b trial for Netherton syndrome, a rare and life-threatening skin disease with no approved treatments. Azitra is also advancing ATR-04, currently in a Phase 1/2 trial, to treat EGFR inhibitor–associated skin toxicity, a condition affecting roughly 150,000 people in the U.S. Supported by a proprietary platform of engineered proteins, live biotherapeutics, and an AI-enhanced microbial library of 1,500 strains, Azitra is pioneering targeted, innovative solutions for severe dermatologic needs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Azitra raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsNorm S., Chief Financial Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Azitra's next move

See what Strategic adds

Azitra raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.